Immunoprophylaxis in Guinea Pigs with Mycobacterium indicus pranii (Mw) in Combination with Standard Chemotherapy of M. tuberculosis Infection Improves Lung Pathology

Autor: V. M. Katoch, Krishan Dutta Rawat, Mohan Natrajan, Reddy Pvj, Nalini Srivastava, Unnati Gupta, Mamta Chahar, Kiran Katoch, D. S. Chauhan

Publikováno v: Mycobacterial Diseases.

Tuberculosis continues to be a major global health problem. BCG (Bacillus Calmette–Guerin) has been used as a vaccine to control tuberculosis, however, the protective value of the vaccine has been reported be highly variable across different popula

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::50fa31e21e69e2efe6ccffbf1f459205
https://doi.org/10.4172/2161-1068.1000230

Performance evaluation of in-house developed Covid-19 IgG/IgM antibody rapid diagnostic kit.

Autor: G VCVS; Genomix CARL Pvt. Ltd, Pulivendula, Andhra Pradesh, 516 390, India.; Department of Biotechnology, Vignan's Foundation for Science, Technology & Research Deemed to be University, Vadlamudi, Guntur, Andhra Pradesh, 522 213, India., Reddy PVJ; Genomix CARL Pvt. Ltd, Pulivendula, Andhra Pradesh, 516 390, India., Suravajhala P; Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Clappana, Kerala, 690525, India. prash@bioclues.org.; Bioclues.org, Hyderabad, India. prash@bioclues.org., Suravajhala R; Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Clappana, Kerala, 690525, India., V UK; Genomix CARL Pvt. Ltd, Pulivendula, Andhra Pradesh, 516 390, India., Pb KK; Department of Genetics, Osmania University, Hyderabad, Telangana, 500 007, India., Tc V; Department of Biotechnology, Vignan's Foundation for Science, Technology & Research Deemed to be University, Vadlamudi, Guntur, Andhra Pradesh, 522 213, India., Polavarapu R; Genomix CARL Pvt. Ltd, Pulivendula, Andhra Pradesh, 516 390, India. giri@genomixbiotech.com.

Publikováno v: AMB Express [AMB Express] 2023 Oct 17; Vol. 13 (1), pp. 116. Date of Electronic Publication: 2023 Oct 17.

Potential of adjunctive Mycobacterium w (MIP) immunotherapy in reducing the duration of standard chemotherapy against tuberculosis.

Autor: Chahar M; National JALMA Institute for Leprosy & Other Mycobacterial Diseases (ICMR), Tajganj, Agra, 282004, UP, India., Rawat KD; National JALMA Institute for Leprosy & Other Mycobacterial Diseases (ICMR), Tajganj, Agra, 282004, UP, India; Department of Bio & Nanotechnology, Guru Jambheshwar University of Science & Technology, Hisar, 125001, India., Reddy PVJ; National JALMA Institute for Leprosy & Other Mycobacterial Diseases (ICMR), Tajganj, Agra, 282004, UP, India., Gupta UD; National JALMA Institute for Leprosy & Other Mycobacterial Diseases (ICMR), Tajganj, Agra, 282004, UP, India., Natrajan M; National JALMA Institute for Leprosy & Other Mycobacterial Diseases (ICMR), Tajganj, Agra, 282004, UP, India., Chauhan DS; National JALMA Institute for Leprosy & Other Mycobacterial Diseases (ICMR), Tajganj, Agra, 282004, UP, India., Katoch K; National JALMA Institute for Leprosy & Other Mycobacterial Diseases (ICMR), Tajganj, Agra, 282004, UP, India., Prasad GBKS; Department of Biochemistry, Jiwaji University, Gwalior, 474011, India., Katoch VM; Former Secretary, Department of Health Research, Govt of India and Director-General, Indian Council of Medical Research, Ansari Nagar, New Delhi, 110029, India. Electronic address: vishwamohan_katoch@yahoo.co.in.

Publikováno v: The Indian journal of tuberculosis [Indian J Tuberc] 2018 Oct; Vol. 65 (4), pp. 335-344. Date of Electronic Publication: 2018 Sep 06.